Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial (Q35475689)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

0 references

multiple sclerosis

0 references

reproducibility

1 reference

based on heuristic

inferred from title

author name string

Lin X

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Tench CR

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Turner B

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Blumhardt LD

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Constantinescu CS

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 August 2003

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

74

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1090-1094

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Disability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Axonal pathology in multiple sclerosis: relationship to neurologic disability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath 1H.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Three dimensional MRI estimates of brain and spinal cord atrophy in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Infratentorial atrophy on magnetic resonance imaging and disability in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

"Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Axonal Transection in the Lesions of Multiple Sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Axonal damage in acute multiple sclerosis lesions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

The cervical cord in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

27 July 2018

Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis--a quantitative T1 relaxation time mapping approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

MRI brain volume changes in relapsing-remitting multiple sclerosis patients treated with interferon beta-1a

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

Axonal loss in normal-appearing white matter in a patient with acute MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

Short-term brain volume change in relapsing-remitting multiple sclerosis: effect of glatiramer acetate and implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

A method of radio-frequency inhomogeneity correction for brain tissue segmentation in MRI.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

Immunogenicity of interferon-beta in multiple sclerosis patients: influence of preparation, dosage, dose frequency, and route of administration. Danish Multiple Sclerosis Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

One year follow up study of primary and transitional progressive multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

Total brain N-acetylaspartate: a new measure of disease load in MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

A high-resolution three-dimensional T1-weighted gradient echo sequence improves the detection of disease activity in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

Serial gadolinium-enhanced MRI of the brain and spinal cord in early relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1738612

26 September 2018

Inflammation and atrophy in multiple sclerosis: MRI associations with disease course

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, comparative study of interferon beta-1a treatment regimens in MS: The EVIDENCE Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation of neutralization of interferon by antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Morphometry of the normal cadaveric cervical spinal cord

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spinal cord atrophy and disability in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A spinal cord MRI study of benign and secondary progressive multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Longitudinal Magnetic Resonance Imaging Study of the Cervical Cord in Multiple Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and significance of neutralizing antibodies to interferon beta-1a in multiple sclerosis. Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Spinal cord atrophy and disability in MS: A longitudinal study

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/12876240

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.74.8.1090

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35475689&oldid=1971525751"